Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus - A randomized study using positron emission tomography

Frank M. Bengel, C. Abletshausert, J. Neverve, O. Schnellt, S. G. Nekolla, E. Standl, M. Schwaiger

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: To evaluate effects of the oral antidiabetic insulinotropic agent nateglinide on myocardial blood flow (MBF) and microvascular reactivity in Type 2 diabetic patients. Methods: Forty-seven Type 2 diabetic patients were randomly assigned 2 : 1 to nateglinide 120 mg (t.i.d., n = 33) or placebo (n = 14). At baseline and after 16 weeks of treatment, MBF was quantified using positron emission tomography with N-13 ammonia at rest, during endothelial-dependent stimulation by cold pressor test and during adenosine-mediated vasodilation. Additional blood samples were taken to assess glycaemic control and lipid profile. Results: MBF at rest and during adenosine did not change during the study. The percentage of flow increase from rest during cold presser test did not improve significantly in the nateglinide group vs. placebo (from 26.1 ± 37.2% to 29.1 ± 27.8% between week O to week 16 for nateglinide vs. 14.9 ± 37.1% to 18.1 ± 28.4% for placebo; P = 0.07 for nateglinide when adjusted for higher baseline values). Nateglinide decreased HbA1c by 0.4% (from 7.6 ± 0.9% to 7.2 ± 1.3%) compared to an increase of 0.5% in the placebo group (from 7.9 ± 0.8% to 8.4 ± 1.7%; P = 0.02 for nateglinide). No differences between the two groups were observed in insulin levels and lipid status. Conclusions: Nateglinide neither improved, nor impaired myocardial blood flow in Type 2 diabetic patients. Potential effects on endothelial-dependent myocardial blood flow remain to be investigated further. Positron emission tomography is a sensitive approach to assess the effects of therapeutic agents on myocardial blood flow in patients with diabetes.

Original languageEnglish (US)
Pages (from-to)158-163
Number of pages6
JournalDiabetic Medicine
Volume22
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Keywords

  • Coronary microcirculation
  • Nateglinide
  • Positron emission tomography
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus - A randomized study using positron emission tomography'. Together they form a unique fingerprint.

Cite this